Larvol Delta - Seattle-AVM-Biotechnology-announces-second-IND-for-AVM0703-clinical-trial-permitted-to-treat-COVID19-and-Influenza-ARDS-with-its-supercharged-version-of-dexamethasone

dexamethasone sodium phosphate (AVM0703) - AVM Biotechnology

https://www.prnewswire.com/news-releases/seattle-avm-biotechnology-announces-second-ind-for-avm0703-clinical-trial-permitted-to-treat-covid-19-and-influenza-ards-with-its-supercharged-version-of-dexamethasone-301131932.html

Sep 16, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next